Ann Clin Microbiol 2025;29(1):4. Antibiotic resistance patterns of pathogenic Escherichia coli isolated from southeastern Korean patients with acute diarrhea from October 2023 to June 2024: a cross-sectional surveillance study

Table 1. Antibiotic resistance profiles of pathogenic Escherichia coli isolates (N = 192)
Antibiotics R (n) S (n) I (n) SDD (n) R (%) S (%)
AMP 148 42 2 0 77.1 22.9
AMC 85 102 5 0 44.3 55.7
PT 30 157 0 5 15.6 81.8
CFZ 106 86 0 0 55.2 44.8
CTX 73 119 0 0 38.0 62.0
CAZ 41 113 38 0 21.4 58.6
FEP 11 172 0 9 5.7 89.6
IPM 1 191 0 0 0.5 99.5
MEM 0 192 0 0 0.0 100.0
ETP 0 191 1 0 0.0 99.5
AMK 1 191 0 0 0.5 99.5
GEN 21 170 1 0 10.9 89.1
CIP 29 68 95 0 15.1 49.5
SXT 67 125 0 0 34.9 65.1
NIT 1 190 1 0 0.5 99.0
ATM 4 188 0 0 2.1 97.9
FOX 4 188 0 0 2.1 97.9
TGC 4 188 0 0 2.1 97.9

Abbreviations: R, resistant; S, susceptible; I, intermediate; SDD, susceptible-dose dependent; AMP, ampicillin; AMC, amoxicillin-clavulanic acid; PT, piperacillin-tazobactam; CFZ, cefazolin; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; IPM, imipenem; MEM, meropenem; ETP, ertapenem; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; SXT, sulfamethoxazole-trimethoprim; NIT, nitrofurantoin; ATM, aztreonam; FOX, cefoxitin; TGC, tigecycline.